Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Payables (2016 - 2025)

INVO Fertility (IVF) has disclosed Payables for 15 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • Quarterly Payables fell 74.9% to $2.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2025, down 74.9% year-over-year, with the annual reading at $4.0 million for FY2024, 21.61% down from the prior year.
  • Payables for Q3 2025 was $2.5 million at INVO Fertility, down from $5.1 million in the prior quarter.
  • The five-year high for Payables was $11.3 million in Q1 2025, with the low at $306252.0 in Q2 2021.
  • Average Payables over 5 years is $3.4 million, with a median of $2.9 million recorded in 2023.
  • The sharpest move saw Payables surged 574.25% in 2023, then crashed 74.9% in 2025.
  • Over 5 years, Payables stood at $896828.0 in 2021, then skyrocketed by 135.46% to $2.1 million in 2022, then skyrocketed by 141.24% to $5.1 million in 2023, then fell by 21.61% to $4.0 million in 2024, then crashed by 36.39% to $2.5 million in 2025.
  • According to Business Quant data, Payables over the past three periods came in at $2.5 million, $5.1 million, and $11.3 million for Q3 2025, Q2 2025, and Q1 2025 respectively.